Methods of Treatment of Endobronchial Infections

Particles for treatment of pulmonary infection

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Compositions and Methods For Increasing the Bioavailability of Pulmonarily Administered Insulin

Use of Dry Powder Compositions For Pulmonary Delivery

UNIT DOSE DRY POWDER INHALER

Salt III

USE OF SIMPLE AMINO ACIDS TO FORM POROUS PARTICLES

USE OF SIMPLE AMINO ACIDS TO FORM POROUS PARTICLES

Two-part capsule to accept pharmaceutical preparations for powder inhalers

Combinations comprising antimuscarinic agents and beta-adrenergic agonists

DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE

DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE

SYSTEMS AND METHODS FOR EFFECTING CESSATION OF TOBACCO USE

Process for preparing a medicament

Dry Powder Inhaler Formulations Comprising Surface-Modified Particles With Anti-Adherent Additives

Preparation of powder agglomerates

Therapeutic Compositions for Pulmonary Delivery

Biocompatible Polymer Compounds For Medicinal Formulations

Method and apparatus for producing dry particles

Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders

PULMONARY DISEASE TREATMENT

Method of Use of Monomeric Insulin as a Means for Improving the Reproducibility of Inhaled Insulin

Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them

METHOD OF USE OF MONOMERIC INSULIN AS A MEANS FOR IMPROVING THE REPRODUCIBILITY OF INHALED INSULIN

Compositions and methods for the prevention and control of insulin-induced hypoglycemia

METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION

Inhalable powders comprising protein, phenylalanine, and other protein stabilizers

Pulmonary delivery of active fragments parathyroid hormone

TEMPERING

Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)

Pharmaceutical Compositions

Pharmaceutical Compositions for Inhalation Containing an Anticholinergic, Corticosteroid, and Betamimetic

Pulmonary delivery of aminoglycoside

Dry Powder Inhalant Composition

Method Of Treating Diabetes Mellitus In A Patient

Drug microparticles

Powder inhaler formulations

Combinations Comprising Antimuscarinic Agents and Corticosteroids

Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections

Dry compositions

Combinations Comprising Antimuscarinic Agents and Beta-Adrenergic Agonists

Particles for inhalation having sustained release properties

Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation Thereof

Human-powered dry powder inhaler and dry powder inhaler compositions

Swellable particles for drug delivery

Soft anticholinergic zwitterions

Pharmaceutical compositions

PULMONARY DELIVERY OF SPHERICAL INSULIN MICROPARTICLES

Method of treating diabetes

METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION

Methods for pulmonary delivery of interleukin-2

Amorphous, spray-dried powders having a reduced moisture content and a high long term stability

Pulmonary Insulin Crystals

METHOD OF PRODUCING A NICOTINE MEDICAMENT AND A MEDICAMENT MADE BY THE METHOD

Quinolinone-carboxamide compounds as 5-HTreceptor agonists

Method for the production of porous particles

Combination of anticholineric and β mimetics for the treatment of respiratory diseases

Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent

Method of Administration of Dopamine Receptor Agonists

Genetic modification of the lung as a portal for gene delivery

Neutralization of bacterial spores

Combinations Comprising Antimuscarinic Agents and Pde4 Inhibitors

Process for Preparing Inhalable Powders

Dry powder pharmaceutical compositions comprising surfactants, hydrophobic active principles, and water-soluble excipients, process of preparing, and stable aqueous suspensions thereof

Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections

Dry powder for inhalation

Dispersion for pulmonary delivery of a bioactive agent

Amelioration of effects of cigarette smoke

Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient

cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction

COMPOSITION OF MATTER

Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent

Aerosol composition comprising formoterol

Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Pharmaceutical compositions of pyrimidine-2,4,6-triones

PHARMACEUTICAL COMPOSITIONS IN PARTICULATE FORM

Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same

Novel m3 muscarinic acetylcholine receptor antagonists

PROCESSES FOR MAKING PARTICLE-BASED PHARMACEUTICAL FORMULATIONS FOR PULMONARY OR NASAL ADMINISTRATION

Process for cleaning hard gelatine capsules

DPI formulation containing sulfoalkyl ether cyclodextrin

DRY POWDER COMPOSITIONS FOR RNA INFLUENZA THERAPEUTICS

Combination comprising antimuscarinic agents and PDE4 inhibitors

INHALABLE BIODEGRADABLE MICROPARTICLES FOR TARGET-SPECIFIC DRUG DELIVERY IN TUBERCULOSIS AND A PROCESS THEREOF

INHALABLE BIODEGRADABLE MICROPARTICLES FOR TARGET-SPECIFIC DRUG DELIVERY IN TUBERCULOSIS AND A PROCESS THEREOF

Insulin highly respirable microparticles

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Pharmaceutical Compositions Based on Tiotropium Salts and Salts of Salmeterol

Aerosolized capreomycin for inhibition of pulmonary tuberculosis

Soft anticholinergic esters

Method of treating mucus hypersecretion

Compositions comprising amphotericin B, mehods and systems

High load particles for inhalation having rapid release properties

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS

Storage stable power compositions of interleukin-4 receptor

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Combination of a dopamine D2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways and other inflammatory diseases

Particulate drug-containing products and method of manufacture

Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof

Pharmaceutical metered dose inhaler and methods relating thereto

Method for administration of tiotropium

Use of simple amino acids to form porous particles

Particulate compositions for pulmonary delivery

Inhalable tiotropium and container therefor

Dronabinol treatment for migraines

Quinuclidine derivatives and medicinal compositions containing the same

Zinc-free and low-zinc insulin preparations having improved stability

Combination of medicaments for the treatment of respiratory diseases

Rapid Acting and Prolonged Acting Inhalable Insulin Preparations

Dry powder composition comprising a benzodiazepine for pulmonary inhalation

Method for the Protection Against the Risk of Cardiac Disorders Comprising Administration of Tiotropium Salts

Aerosol powder formulation

Composition

Dry powder formulations

Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations

Novel Dry Powder Inhalation System For Transpulmonary Administration

Acute treatment of social phobia

Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same

Method of engineering particles for use in the delivery of drugs via inhalation

Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation

Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments

Trospium containing compositions

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Powdered Medicaments Containing A Tiotropium Salt and Salmeterol Xinafoate

METHOD OF PRESERVING THE FUNCTION OF INSULIN-PRODUCING CELLS

Use of ciclesonide for the treatment of respiratory diseases

Pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins

Dispersible macromolecule compositions and methods for their preparation and use

Potentiation of glucose elimination

Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament

Particles for inhalation having sustained release properties

Process for Cleaning Hard Gelatine Capsules

Inhalation compositions with high drug ratios

Methods for preparing pharmaceutical compositions

Medicament compositions comprising a heterocyclic compound and an anticholinergic

Spray freeze dried liposomal ciprofloxacin powder aerosol drug delivery

Aerosolized fluoroquinolones and uses thereof

Medicaments comprising steroids and a novel anticholinergic

Radial spherical crystallization product, process for producing the same, and dry powder preparation containing the crystallization product

Dry powder composition comprising co-jet milled particles for pulmonary inhalation

Powdery pharmaceutical compositions for inhalation

Medical product

Dry powder inhaler system

Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases

New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies

Method for the administration of an anticholinergic by inhalation

Use of osmolytes obtained from extremophilic bacteria the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component

Superior control of blood glucose in diabetes treatment

Medical product

Pharmaceutical formulations comprising magnesium stearate

Drug for airway administration

Inhalative powder formulations containing the CGRP-antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine

Method for the Administration of an Anticholinergic by Inhalation

Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof

Combinations comprising antimuscarinic agents and corticosteroids

Treatment of mucosal membranes

Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors

Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections

Combinations comprising antimuscarinic agents and beta-adrenergic agonists

Pharmaceutical compositions based on anticholinergics and pegsunercept

Pharmaceutical compositions comprising apomorphine for pulmonary inhalation

Pulmonary delivery particles comprising water insoluble or crystalline active agents

Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Pulmonary delivery particles with phospholipid structural matrix

Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use

Two-part capsule with pre-closure for housing pharmaceutical preparations for powder inhalers

Combinations comprising antimuscarinic agents and PDE4 inhibitors

Methods and compositions for minimizing accrual of inhalable insulin in the lungs

Formulation of fine particles using liquefield or dense gases

Stabilized pharmaceutical product

Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation

Medicaments for the Treatment or Prevention of Fibrotic Diseases

Low dose corticosteroid powders for inhalation

Compositions and methods for pulmonary conditions

Chemical carrier based on a beta-limit dextrin

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Surface modification of lactose excipient for use in powders for inhalation

Medical product for inhalation containing glucagon-like peptide-1 (GLP-1)

Powdered inhalants based on modified lactose mixtures as excipient

Quinuclidine derivatives and medicinal compositions containing the same

Quinuclidine derivatives and medicinal compositions containing the same

Manufacture of particles for pulmonary drug delivery by carbon dioxide assisted nebulization

Stable pharmaceutical products

Pulmonary delivery of inhibitors of phosphodiesterase type 5

Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger

Methods for making pharmaceutical formulations comprising deagglomerated microparticles

Methods for making pharmaceutical formulations comprising deagglomerated microparticles

Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin

Particle formulation and its preparation

Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline

Therapeutic treatments using the direct application of antimicrobial metal compositions

Combination of formoterol and a tiotropium salt

Sustanined-release pharmaceutical composition for lung administration

Dry powder inhalation system for transpulmonary administration

Medicaments for inhalation comprising steroids and an anticholinergic

Metered medication dose

Inhalable lidocaine formulation for treatment of asthma and for reducing the need for corticosteroids in asthmatic patients

Method for improvement of tolerance for therapeutically effective agents delivered by inhalation

Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks

Drug delivery particles and methods of treating particles to improve their drug delivery capabilities

Freeze-dried interferon-y composition for transpulmonary administration and inhalation system therefor

Diketopiperazine salts for drug delivery and related methods

Method and apparatus for producing dry particles

Methotrexate compositions

Inhalable powder containing tiotropium

Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids

Carrier particles for use in dry powder inhalers

Compositions comprising amphotericin B, methods, and systems

Method for treating carrier particles and its use

Combination of formoterol and mometasone furoate for asthma

Synthesis and powder preparation of fluticasone propionate

Stable spray-dried protein formulations

Pharmaceutical porous particles

Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist

Combinations comprising antimuscarinic agents and corticosteroids

Use of mometasone furoate for treating airway passage and lung disease

Combinations of formoterol and fluticasone propionate for asthma

Process for preparing stable SOL of pharmaceutical ingredients and hydrofluorocarbon

Treatment of inflammatory skin conditions

Combinations comprising antimuscarinic agents and PDE4 inhibitors

Combinations comprising antimuscarinic agents and beta-adrenergic agonists

Pulmonary malarial vaccine

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease

Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts

Formoterol and mometasone aerosol formulations

Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases

Powder comprising new compositions of oligosaccharides and methods for their preparation

Mucin synthesis inhibitors

Aerodynamically light particles for pulmonary drug delivery

Dry powder compositions

Process and apparatus for producing inhalable medicaments

Sealed capsule including an integrated puncturing mechanism

Dry powder inhalant composition

Use of compounds in a dry powder inhaler

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis

Anticholinergic powder formulations for inhalation

Formulations limiting spread of pulmonary infections

Process for producing fine medicinal substance

Lipid formulations for spontaneous drug encapsulation

Dry powder preparations

Quinuclidine derivatives and medicinal compositions containing the same

Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases

High storage stability inhalable compositions

Polysaccharides for pulmonary delivery of active agents

Stabilized preparations for use in nebulizers

Diphenylmethyl compounds useful as muscarinic receptor antagonists

Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets

Pharmaceutical formulations

Excipient for use in dry powder inhalation preparations

Powder inhaler formulations

Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols

Particles for inhalation having rapid release properties

Method of manufacturing chemical-containing composite particles

Interleukin-13 antagonist powders, spray-dried particles, and methods

Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation

Process of forming and modifying particles and compositions produced thereby

Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases

Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist

Process for the treatment of particles for use in pharmaceutical formulations

Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions

Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors

Powdery respiratory tonic composition

Synthesis of small particles

Delivery of oral drugs

Aerodynamically light particles for pulmonary drug delivery

Method of preparing dry powder inhalation compositions

Pharmaceutical compositions based on a scopineester and nicotinamide derivatives

Powders comprising anti-adherent materials for use in dry powder inhalers

Novel formulation

Pulmonary disease treatment

Pharmaceutical compositions based on anticholinergics and additional active ingredients

Compositions comprising an active agent

Compositions for pulmonary administration

Method for the production and the use of microparticles and nanoparticles by constructive micronisation

Aerosol composition comprising formoterol

Storage stable powder compositions of interleukin-4 receptor

Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections

Medical product

Modulating charge density to produce improvements in the characteristics of spray-dried proteins

Medical product containing tiotropium

Pre-metered dry powder inhaler for moisture-sensitive medicaments

Inhalable tiotropium and container therefor

Method for administration of tiotropium

Pulmonary insulin crystals

Powder particles with smooth surface for use in inhalation therapy

Pulmonary delivery of a liquid medicament aerosol

Therapeutic regimens for administering drug combinations

Treatment of cancers by inhalation of stable platinum-containing formulations

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

Selective targeting of apoptotic cells

Treatment of disease or injury of the nervous system with FTY720

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease

Sustained-release compositions

Capsules containing inhalable tiotropium